Chronic myeloproliferative neoplasms (MPNs) are hematopoietic stem cell neoplasms with
driver events including the BCR-ABL1 translocation leading to a diagnosis of chronic …

Abstract Background Janus kinase 2 (JAK2) V617F gene mutation is an important marker for
the diagnosis of Philadelphia negative Myeloproliferative neoplasms (MPN) which is …

Background. JAK2 V617F (JAK2) mutation is associated with clonal hemopoiesis in
myeloproliferative neoplasms as well as with faster progression of cardiovascular diseases …

Objetivos: Evaluar la influencia de la carga alélica de la mutación JAK2V617F y su relación
con variables clínico-hematológicas en el diagnóstico de estas enfermedades en pacientes …

Myeloproliferative neoplasms have a high prevalence and genetic mutations play a role in
their occurrence. Determination of these mutations can be valuable in the screening …

The past two decades have seen a plethora of studies and observations on driver and non-
molecular alterations of prognostic significance in myeloproliferative neoplasm. In this …

A male patient with a persistent, combined erythrocytosis, leukocytosis, and thrombocytosis
without representative evidence of reactive increase emerged as having a myeloproliferative …